AbbVie Earnings
NYSE: ABBVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 3:43 PM ET
Next earnings date
Fri, Oct 30, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$3.77
AbbVie earnings summary
AbbVie is scheduled to report Sep/2026 earnings on Oct 30, 2026 before the market opens, with analysts expecting EPS of $3.77. In its most recent report on Aug 3, 2026 (Q2 2026), ABBV posted EPS of $2.03. Revenue for the quarter was $16.99 billion.
Quarterly EPS is up 290.4% from the same quarter a year earlier. Across the last 16 reports, ABBV shares moved an average of 3.3% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
ABBV earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 3, 2026 | — | $2.03 | — | +1.4% |
| May 8, 2026 | — | $0.39 | — | +4.4% |
| Feb 20, 2026 | — | $1.02 | — | +3.2% |
| Nov 4, 2025 | — | $0.10 | — | +6.0% |
| Aug 4, 2025 | — | $0.52 | — | +4.4% |
| May 9, 2025 | — | $0.72 | — | -0.3% |
| Feb 14, 2025 | — | $-0.02 | — | +4.8% |
| Nov 4, 2024 | — | $0.88 | — | -17.3% |
| Aug 7, 2024 | — | $0.77 | — | +2.1% |
| May 3, 2024 | — | $0.77 | — | -1.9% |
| Feb 20, 2024 | — | $0.46 | — | +0.5% |
| Nov 6, 2023 | — | $1.00 | — | -0.2% |
| Aug 7, 2023 | — | $1.14 | — | -1.3% |
| May 5, 2023 | — | $0.13 | — | -0.6% |
| Feb 17, 2023 | — | $1.38 | — | +0.9% |
| Nov 4, 2022 | — | $2.21 | — | +3.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.